The Antibody Discovery Specialists.

We are antibody enthusiasts working to discover biologics that target the most challenging classes of therapeutic targets.


Learn about our platform


Technology Spotlight: DiversimAb Platform


100+ Successful Discovery Campaigns Targeting Cell Surface receptors.

Industry-leading solutions for therapeutic and reagent antibody developers. We have built a strong reputation on our ability to deliver outstanding science. We have custom-built gene-to-antibody solutions to support development efforts for:

  • Therapeutic antibodies against difficult targets such as GPCR, ion channels, glycan targets
  • Cell therapies
  • Point-of-care diagnostics
  • Reagent & anti-idiotypic antibodies supporting clinical trials
  • Anywhere else antibodies are needed
ForteBio Octet Berkeley Lights primary-slate@2x logo-carterra intellicyt ACRO_LOGO (1) Harbour Biomed Logo Hamilton logo Tecan-logo

The Reviews Are In.

Pharma and biotech of various sizes and pipelines rely on Abveris.

"Our platform rapidly generates and validates new targets for treating challenging cancers. Working with Abveris will enable us to quickly identify and select highly specific antibodies for those targets, so that we can take the best antibody forward to address the needs of particular patient populations."

Jeff Goldberg


Immunitas Therapeutics

Speak with Abveris scientists about how to tackle challenges in antibody discovery.

Abveris News